Deuterium-Labeled Lipid Detection for Rapid Antibiotic Susceptibility Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibiotic susceptibility tests are slow and do not fully utilize the high-throughput and sensitivity of mass spectrometry techniques, leading to prolonged turn-around times in clinical settings.
Innovation Solution
The method involves stable isotope labeling of bacterial membrane lipids using deuterium oxide (D2O) and MALDI-MS to rapidly detect deuterium incorporation in lipids, allowing for the determination of antibiotic susceptibility by measuring metabolic responses in bacterial cultures, which can be completed in as little as half an hour.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional broth dilution or agar dilution methods are used for antibiotic susceptibility testing, then MIC information can be obtained regardless of resistance mechanism, but the culture time is long leading to slow turn-around time
Solution Approach 1:
The patent replaces traditional mechanical/optical detection methods (visual inspection of growth in broth dilution or agar dilution) with mass spectrometry detection. The MALDI-MS system detects deuterium-labeled lipids from bacterial cells, providing MIC information through mass spectral analysis rather than traditional growth-based methods, thereby reducing turn-around time while maintaining accuracy.
Solution Approach 2:
The patent changes the detection parameter from measuring bacterial growth inhibition directly (traditional methods) to measuring deuterium incorporation into bacterial lipids via mass spectrometry. By tracking the incorporation of deuterium from D2O into lipid molecules during a short culture period, the method determines MIC values without requiring long culture times, thus resolving the time-accuracy contradiction.
2Loss of time
If PCR amplification of resistance genes or immunoassays are used, then rapid identification of known resistance genes can be achieved, but no MIC information is provided and databases may not be comprehensive
Solution Approach 1:
The patent creates a universal testing method that simultaneously provides both rapid identification capability and MIC determination. The MALDI-MS approach with deuterium labeling can identify bacterial strains and determine MIC values in a single assay, making the system multi-functional unlike PCR or immunoassays which are specialized for gene detection only.
Solution Approach 2:
The patent uses deuterium-labeled lipids as an intermediary marker to bridge the gap between rapid detection and MIC determination. Instead of directly measuring growth inhibition or gene presence, the method tracks deuterium incorporation into lipids as a proxy for metabolic activity and growth, thereby providing MIC information rapidly without requiring comprehensive resistance gene databases.
3Loss of time
If stable isotope labeling with deuterium oxide is used to track metabolic changes, then rapid detection of bacterial growth can be achieved, but the method complexity increases
Solution Approach 1:
The patent employs a self-service approach where bacterial cells themselves perform the labeling by incorporating deuterium from D2O into their own lipid molecules during normal growth. The cells act as their own labeling factories, eliminating the need for external labeling reagents or complex labeling procedures, thereby reducing method complexity while maintaining rapid detection capability.
Solution Approach 2:
The patent extracts and analyzes only the deuterium-labeled lipid fraction from the complex bacterial mixture using mass spectrometry. By focusing detection on the specific mass spectral signature of deuterium-labeled lipids rather than analyzing all cellular components, the method simplifies the analytical process and reduces complexity while enabling rapid growth detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces culture time, providing rapid and accurate antibiotic susceptibility results, capable of identifying resistant strains and determining minimum inhibitory concentrations (MIC) with high throughput and sensitivity, applicable to various bacterial strains and resistance mechanisms.
Implementation Method 1
Incorporation of a deuterium label (D-label) into newly synthesized lipids can be easily detected by mass spectrometry and by using this method, one can determine if bacteria are growing, dividing, and producing new lipids
Implementation Method 2
MALDI-MS has been recently used for AMR detection beyond bacterial identification. Idelevich et al. developed an AST using on-target microdroplet culture of bacteria to detect cell growth by protein fingerprinting
Data Source
AI summary
An antimicrobial susceptibility test was developed that utilizes deuterium labeling of membrane lipids to track the growth of bacterial cells. Deuterium labeling of lipids can be detected using matrix-assisted laser desorption/ionization mass spectrometry. Additionally, bacteria growth is performed on the MALDI target, minimizing sample preparation materials and time. The labeling efficiency, or the ratio of labeled to unlabeled lipid peaks, provides information about the growth rate of bacteria. This growth ratio can differentiate between resistant and susceptible strains of bacteria as a resistant strain will maintain ˜50% labeling efficiency between untreated and treated cultures. In comparison, a susceptible strain will see a decrease in fractional abundance of deuterium from ˜50% in the untreated to ˜10% in the treated. This approach is applied to measure the minimum inhibitory concentration of the resistant and susceptible strains from on-target microdroplet culture in a range of antibiotic concentrations.